title: Adolescents and young adults with a "rare" cancer: getting past semantics to optimal care for patients with germ cell tumors.
authors.affiliation: Children's and Young Persons Cancer Services, University College London Hospital Trusts, London, United Kingdom; sara.stoneham@uclh.nhs.uk.
authors.forename: Sara J
authors.initials: SJ
authors.lastname: Stoneham
authors.affiliation: Department of Paediatric Oncology, Royal Victoria Infirmary, Newcastle upon Tyne Hospitals trust, Newcastle upon Tyne, United Kingdom;
authors.forename: Juliet P
authors.initials: JP
authors.lastname: Hale
authors.affiliation: Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts, USA;
authors.forename: Carlos
authors.initials: C
authors.lastname: Rodriguez-Galindo
authors.affiliation: Children's Oncology Group, Monrovia, California, USA;
authors.forename: Ha
authors.initials: H
authors.lastname: Dang
authors.affiliation: Department of Pediatric Oncology, Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia, USA;
authors.forename: Thomas
authors.initials: T
authors.lastname: Olson
authors.affiliation: Department of Paediatric Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom; Department of Pathology, University of Cambridge, Cambridge, United Kingdom;
authors.forename: Matthew
authors.initials: M
authors.lastname: Murray
authors.affiliation: University of Texas Southwestern Medical Center and Children's Medical Center, Dallas, Texas, USA;
authors.forename: James F
authors.initials: JF
authors.lastname: Amatruda
authors.affiliation: Department of Pathology, Royal Victoria Hospital, Belfast Health Trust, Belfast, United Kingdom;
authors.forename: Claire
authors.initials: C
authors.lastname: Thornton
authors.affiliation: Department of Pediatric Surgery, Birmingham Children's Hospital NHS Foundation Trust, Birmingham, United Kingdom;
authors.forename: G Suren
authors.initials: GS
authors.lastname: Arul
authors.affiliation: Riley Hospital for Children, Indianapolis, Indiana, USA;
authors.forename: Deborah
authors.initials: D
authors.lastname: Billmire
authors.affiliation: Children's Oncology Group, Monrovia, California, USA;
authors.forename: Mark
authors.initials: M
authors.lastname: Krailo
authors.affiliation: Department of Medical Oncology, St. James's Institute of Oncology, St. James University Hospital, Leeds, United Kingdom;
authors.forename: Dan
authors.initials: D
authors.lastname: Stark
authors.affiliation: Department of Gynecology Oncology, University of Toronto, Sunnybrook Health Sciences Center, Ontario, Canada;
authors.forename: Al
authors.initials: A
authors.lastname: Covens
authors.affiliation: Department of Gynecologic Oncology, North Shore University Health System, Evanston, Illinois, USA;
authors.forename: Jean
authors.initials: J
authors.lastname: Hurteau
authors.affiliation: Medical Research Council Clinical Trials Unit, London, United Kingdom.
authors.forename: Sally
authors.initials: S
authors.lastname: Stenning
authors.affiliation: Department of Paediatric Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom;
authors.forename: James C
authors.initials: JC
authors.lastname: Nicholson
authors.affiliation: University of Texas Southwestern Medical Center and Children's Medical Center, Dallas, Texas, USA;
authors.forename: David
authors.initials: D
authors.lastname: Gershenson
authors.affiliation: Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts, USA;
authors.forename: A Lindsay
authors.initials: AL
authors.lastname: Frazier
mesh_terms: D000293:Adolescent; D000328:Adult; D005260:Female; D006801:Humans; D008297:Male; D009373:Neoplasms, Germ Cell and Embryonal / Q000139:chemically induced* / Q000473:pathology / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D035583:Rare Diseases / Q000145:classification* / Q000473:pathology / Q000628:therapy*; D055815:Young Adult
keywords: Adolescence; Germ cell tumors; Risk stratification; Young adults